Parnell Pharmaceuticals Holdings - 11 Year Stock Price History | PARNF
Historical daily share price chart and data for Parnell Pharmaceuticals Holdings since 2014 adjusted for splits and dividends. The latest closing stock price for Parnell Pharmaceuticals Holdings as of April 22, 2025 is 0.08.
- The all-time high Parnell Pharmaceuticals Holdings stock closing price was 8.17 on June 23, 2014.
- The Parnell Pharmaceuticals Holdings 52-week high stock price is 0.35, which is 337.5% above the current share price.
- The Parnell Pharmaceuticals Holdings 52-week low stock price is 0.00, which is 100% below the current share price.
- The average Parnell Pharmaceuticals Holdings stock price for the last 52 weeks is 0.04.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Parnell Pharmaceuticals Holdings Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2025 |
0.1006 |
0.1800 |
0.1800 |
0.0800 |
0.0800 |
-2.44% |
| 2024 |
0.0050 |
0.0001 |
0.1100 |
0.0001 |
0.0820 |
81900.00% |
| 2023 |
0.0016 |
0.0025 |
0.0200 |
0.0001 |
0.0001 |
-96.00% |
| 2022 |
0.0016 |
0.0001 |
0.0025 |
0.0001 |
0.0025 |
2400.00% |
| 2021 |
0.2256 |
0.3600 |
0.4200 |
0.0001 |
0.0001 |
-99.97% |
| 2020 |
0.1638 |
0.1150 |
0.3890 |
0.0400 |
0.3520 |
206.09% |
| 2019 |
0.2252 |
0.1800 |
0.4000 |
0.0700 |
0.1150 |
-27.22% |
| 2018 |
0.3622 |
0.4501 |
0.7400 |
0.0850 |
0.1580 |
-73.67% |
| 2017 |
0.7953 |
0.9950 |
1.3200 |
0.3000 |
0.6000 |
-13.06% |
| 2016 |
1.8296 |
3.8544 |
3.8544 |
0.6582 |
0.6901 |
-82.21% |
| 2015 |
4.2713 |
4.7600 |
5.7500 |
3.2560 |
3.8800 |
-6.51% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Parnell Pharmaceuticals Holdings Ltd. is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing animal health solutions. It manufactures and markets cattle reproduction, cattle mastitis, anesthetics, laminitis treatment, and orthopedic treatment products. The Company operates in four segments: Companion Animal, Production Animal-Unites States, and Production Animal-rest of the world and Manufacturing Operations. ZYDAX (R), GLYDE (R) and TERGIVE (R) are Parnell's premium osteoarthritis product suite. Parnell Pharmaceuticals Holdings Ltd. is headquartered in Alexandria, Australia.
|
